Adipose Tissue: An Emerging Target for Adeno-associated Viral Vectors

Adipose Tissue: An Emerging Target for Adeno-associated Viral Vectors

Adipose tissue is one of the largest organs, playing important roles in physiology and pathologies of multiple diseases. However, research related to adeno-associated virus (AAV) targeting adipose tissue has been left far behind studies carried out in the liver, brain, heart, and muscle. Despite ini...

Full description

Bibliographic Details
Main Authors:	Rhiannon Bates, Wei Huang, Lei Cao
Format:	Article
Language:	English
Published:	Elsevier 2020-12-01
Series:	Molecular Therapy: Methods & Clinical Development
Subjects:	AAV adipose gene therapy tissue tropism capsid engineering
Online Access:	http://www.sciencedirect.com/science/article/pii/S2329050120301947

Similar Items

Comparison of analytical techniques to quantitate the capsid content of adeno-associated viral vectors
by: Amanda K. Werle, et al.
Published: (2021-12-01)

Biophysical characterization of adeno-associated virus capsid through the viral transduction life cycle
by: Yanqiao Shawn Xiang, et al.
Published: (2023-05-01)

Efficient gene delivery and selective transduction of astrocytes in the mammalian brain using viral vectors
by: Nicolas eMerienne, et al.
Published: (2013-07-01)

Defining Phenotype, Tropism, and Retinal Gene Therapy Using Adeno-Associated Viral Vectors (AAVs) in New-Born Brown Norway Rats with a Spontaneous Mutation in <i>Crb1</i>
by: Nanda Boon, et al.
Published: (2021-03-01)

Applying machine learning to predict viral assembly for adeno-associated virus capsid libraries
by: Andrew D. Marques, et al.
Published: (2021-03-01)

Adeno-associated viral capsid stability on anion exchange chromatography column and its impact on empty and full capsid separation
by: Ohnmar Khanal, et al.
Published: (2023-12-01)

Adding recombinant AAVs to the cancer therapeutics mix
by: Patrick L. Mulcrone, et al.
Published: (2022-12-01)

Next Step in Gene Delivery: Modern Approaches and Further Perspectives of AAV Tropism Modification
by: Maxim A. Korneyenkov, et al.
Published: (2021-05-01)

Capsid-modified adeno-associated virus vectors as novel vaccine platform for cancer immunotherapy
by: Ann-Christin Franke, et al.
Published: (2023-06-01)

Visceral adipose tissue-directed FGF21 gene therapy improves metabolic and immune health in BTBR mice
by: Nicholas J. Queen, et al.
Published: (2021-03-01)

Engineered AAV2.7m8 Serotype Shows Significantly Higher Transduction Efficiency of ARPE-19 and HEK293 Cell Lines Compared to AAV5, AAV8 and AAV9 Serotypes
by: Dzerassa Gurtsieva, et al.
Published: (2024-01-01)

Emerging Issues in AAV-Mediated In Vivo Gene Therapy
by: Pasqualina Colella, et al.
Published: (2018-03-01)

Seek and destroy: targeted adeno-associated viruses for gene delivery to hepatocellular carcinoma
by: Bijay Dhungel, et al.
Published: (2017-01-01)

Adeno-associated viral vectors at the frontier between tolerance and immunity
by: Federico eMingozzi, et al.
Published: (2015-03-01)

Adeno-Associated Viruses (AAV) and Host Immunity – A Race Between the Hare and the Hedgehog
by: Kleopatra Rapti, et al.
Published: (2021-10-01)

In Situ Detection of Adeno-associated Viral Vector Genomes with SABER-FISH
by: Sean K. Wang, et al.
Published: (2020-12-01)

A role for adeno-associated viral vectors in gene therapy
by: Renata dos Santos Coura, et al.
Published: (2008-01-01)

Adeno-Associated Virus (AAV) Capsid Stability and Liposome Remodeling During Endo/Lysosomal pH Trafficking
by: Bridget Lins-Austin, et al.
Published: (2020-06-01)

Adeno-Associated Virus (AAV) - Based Gene Therapies for Retinal Diseases: Where are We?
by: Ail D, et al.
Published: (2023-05-01)

AAV2 and AAV9 tropism and transgene expression in the mouse eye and major tissues after intravitreal and subretinal delivery
by: Sanna Koponen, et al.
Published: (2023-07-01)

Fast and high-throughput LC-MS characterization, and peptide mapping of engineered AAV capsids using LC-MS/MS
by: Anh K. Lam, et al.
Published: (2022-12-01)

Mapping the AAV capsid host antibody response towards the development of second generation gene delivery vectors
by: Yu-Shan eTseng, et al.
Published: (2014-01-01)

Modifying immune responses to adeno-associated virus vectors by capsid engineering
by: Martin Bentler, et al.
Published: (2023-09-01)

A robust and flexible baculovirus-insect cell system for AAV vector production with improved yield, capsid ratios and potency
by: Yoko Marwidi, et al.
Published: (2024-06-01)

Identification of AAV serotypes for lung gene therapy in human embryonic stem cell-derived lung organoids
by: Helena Meyer-Berg, et al.
Published: (2020-10-01)

Comparison of Different Liquid Chromatography-Based Purification Strategies for Adeno-Associated Virus Vectors
by: Ruth Rieser, et al.
Published: (2021-05-01)

Various AAV Serotypes and Their Applications in Gene Therapy: An Overview
by: Shaza S. Issa, et al.
Published: (2023-03-01)

Infectivity of adeno-associated virus serotypes in mouse testis
by: Santhanasabapathy Rajasekaran, et al.
Published: (2018-11-01)

Biology of Adeno-Associated Viral Vectors in the Central Nervous System
by: Giridhar eMurlidharan, et al.
Published: (2014-09-01)

Adeno-associated viral vector delivered RNAi for gene therapy of SOD1 Amyotrophic Lateral Sclerosis
by: Lorelei Stoica, et al.
Published: (2016-08-01)

Directed evolution of adeno-associated virus 5 capsid enables specific liver tropism
by: Yuqiu Wang, et al.
Published: (2022-06-01)

Fantastic AAV Gene Therapy Vectors and How to Find Them—Random Diversification, Rational Design and Machine Learning
by: Jonas Becker, et al.
Published: (2022-07-01)

Hepatocellular Carcinoma Is a Natural Target for Adeno-Associated Virus (AAV) 2 Vectors
by: Nadja Meumann, et al.
Published: (2022-01-01)

Hyperthermia Enhances Adeno-Associated Virus Vector Transduction Efficiency in Melanoma Cells
by: Alicja Bieńkowska-Tokarczyk, et al.
Published: (2023-10-01)

Rationale and strategies for the development of safe and effective optimized AAV vectors for human gene therapy
by: Arun Srivastava
Published: (2023-06-01)

Adeno-Associated Viral Vectors as Versatile Tools for Neurological Disorders: Focus on Delivery Routes and Therapeutic Perspectives
by: Ana Fajardo-Serrano, et al.
Published: (2022-03-01)

Evaluation of engineered AAV capsids for hepatic factor IX gene transfer in murine and canine models
by: David M. Markusic, et al.
Published: (2017-05-01)

Schwannoma Gene Therapy via Adeno-Associated Viral Vector Delivery of Apoptosis-Associated Speck-like Protein Containing CARD (ASC): Preclinical Efficacy and Safety
by: Sherif G. Ahmed, et al.
Published: (2022-01-01)

In Vivo Gene Editing of Muscle Stem Cells with Adeno-Associated Viral Vectors in a Mouse Model of Duchenne Muscular Dystrophy
by: Jennifer B. Kwon, et al.
Published: (2020-12-01)

Strong ubiquitous micro-promoters for recombinant adeno-associated viral vectors
by: Sunghee Chai, et al.
Published: (2023-06-01)